Article
Structure-Guided Repurposing of SARS-CoV-2 Compounds Identifies Putative Inhibitors of Mpox Viral Enzymes
2026-08-13
Abstract excerpt
<title>Abstract</title> <p>Mpox remains a therapeutically underserved orthopoxvirus infection, and clinical evidence reinforces the need for antivirals acting through mechanisms distinct from tecovirimat. This study investigated whether a SARS-CoV-2 antiviral chemical library could be repurposed against three structurally characterised Mpox targets: the core protease, VP39 mRNA cap methyltransferase and poxin nuc...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 16a5b689-4137-543e-8b14-32046ab28550
- DOI
- 10.21203/rs.3.rs-10617852/v1
